Mark Melzer
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 8
- Infection Control in Healthcare 5
- Epidemiology 18
- Urinary Tract Infections Management 5
- Pneumonia and Respiratory Infections 4
- Sepsis Diagnosis and Treatment 4
- Infective Endocarditis Diagnosis and Management 4
- Co-authors
- Irene Petersen (5 shared papers)Catherine A. Welch (10 shared papers)William R. Gransden (3 shared papers)Susannah J Eykyn (2 shared papers)Susan Chinn (1 shared paper)Sandra Lacey (4 shared papers)Greta Rait (2 shared papers)Richard W. Toner (1 shared paper)
- Journals
- Journal of Infection (9 papers)Postgraduate Medical Journal (6 papers)Journal of Hospital Infection (5 papers)Infection (3 papers)The Lancet Infectious Diseases (3 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Mark Melzer
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Applied Microbiology and Biotechnology 98
- Molecular Medicine 273
- Infectious Diseases 440
- Clinical Biochemistry 60
- Endocrinology 43
Countries citing papers authored by Mark Melzer
This map shows the geographic impact of Mark Melzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Melzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Melzer more than expected).
Fields of papers citing papers by Mark Melzer
This network shows the impact of papers produced by Mark Melzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Melzer. The network helps show where Mark Melzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Melzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 232 | |
| 2 | 2015 | 225 | |
| 3 | 2003 | 205 | |
| 4 | 2007 | 102 | |
| 5 | 2015 | 62 | |
| 6 | 2013 | 57 | |
| 7 | 2000 | 55 | |
| 8 | 2006 | 45 | |
| 9 | 2013 | 43 | |
| 10 | 2011 | 25 | |
| 11 | 2017 | 23 | |
| 12 | 2018 | 19 | |
| 13 | 2012 | 15 | |
| 14 | 2018 | 12 | |
| 15 | 2005 | 11 | |
| 16 | 1998 | 10 | |
| 17 | 2013 | 10 | |
| 18 | 2023 | 10 | |
| 19 | 2000 | 9 | |
| 20 | 1999 | 8 |
About Mark Melzer
Mark Melzer is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Applied Microbiology and Biotechnology and Virology, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (8 papers), Antibiotic Resistance in Bacteria (6 papers), Urinary Tract Infections Management (5 papers), Infection Control in Healthcare (5 papers), Pneumonia and Respiratory Infections (4 papers), Sepsis Diagnosis and Treatment (4 papers), Infective Endocarditis Diagnosis and Management (4 papers) and Infectious Diseases and Tuberculosis (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (98 citations), Molecular Medicine (273 citations), Infectious Diseases (440 citations), Clinical Biochemistry (60 citations) and Endocrinology (43 citations). Mark Melzer has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Irene Petersen, Catherine A. Welch, William R. Gransden, Susannah J Eykyn, Susan Chinn, Sandra Lacey, Greta Rait, Richard W. Toner, David Goldsmith and Julie Watson. Their work appears in journals such as Journal of Infection, Postgraduate Medical Journal, Journal of Hospital Infection, Infection and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.